- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mood Swing in Japan
Total 85 results
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedDepressive DisorderJapan
-
Novartis VaccinesCompletedSwine-Origin Influenza A H1N1 VirusJapan
-
ShionogiEli Lilly and CompanyTerminated
-
Novartis VaccinesCompletedSwine-Origin Influenza A H1N1 VirusJapan
-
ShionogiEli Lilly and CompanyCompletedDepressive DisorderJapan
-
Ashikaga Red Cross HospitalCompleted
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Kyoto UniversityNagoya City UniversityCompleted
-
Mochida Pharmaceutical Company, Ltd.PfizerCompleted
-
Gunma UniversityCompletedSubthreshold DepressionJapan
-
Kibi International UniversityCompleted
-
Kibi International UniversityCompletedSubthreshold DepressionJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
Novartis VaccinesCompletedSwine-Origin Influenza A H1N1 VirusJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Chiba UniversityCompletedAdolescent | DepressionJapan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruiting
-
Astellas Pharma IncCompleted
-
PfizerCompletedFood | Therapeutic EquivalencyJapan
-
National Center of Neurology and Psychiatry, JapanCompletedAnxiety Disorders | Depressive DisordersJapan
-
Astellas Pharma IncCompleted
-
Showa UniversityCompletedMajor Depressive DisorderJapan
-
National Center of Neurology and Psychiatry, JapanCompletedDepressive Disorder | Anxiety DisordersJapan
-
Nagoya City UniversityCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Institute for Health Economics and Policy, JapanSenzoku Stress Coping Support OfficeRecruiting
-
National Center of Neurology and Psychiatry, JapanTerminatedDepression | Alzheimer DiseaseJapan
-
Kibi International UniversityUnknown
-
Nagoya City UniversityKochi UniversityCompletedMajor Depressive DisorderJapan
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)Japan
-
University of JazanSaudi Board of Community MedicineCompletedDepression Literacy | Depression StigmaSaudi Arabia
-
Eli Lilly and CompanyCompleted
-
GlaxoSmithKlineTerminatedDepressive DisorderJapan
-
GlaxoSmithKlineCompletedDepressive DisorderJapan
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
PfizerCompleted
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderJapan
-
TakedaCompletedInsomnia | Major Depressive DisorderJapan
-
Nazlin WaljiRecruitingBipolar DisorderUnited States, Canada, Japan, United Kingdom
-
Sumitomo Pharma Co., Ltd.CompletedBipolar DepressionLithuania, Malaysia, Russian Federation, Slovakia, Ukraine, Japan, Philippines, Taiwan
-
Eli Lilly and CompanyActive, not recruitingAicardi Goutieres Syndrome | Nakajo-Nishimura Syndrome | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome | STING-Associated Vasculopathy With Onset in InfancyJapan
-
GlaxoSmithKlineCompletedDepressive DisorderKorea, Republic of, Japan
-
GlaxoSmithKlineCompletedDepressive Disorder, MajorKorea, Republic of, Japan